Next Article in Journal
Chitosans and Nanochitosans: Recent Advances in Skin Protection, Regeneration, and Repair
Previous Article in Journal
Turning a Targeting β-Catenin/Bcl9 Peptide Inhibitor into a GdOF@Au Core/Shell Nanoflower for Enhancing Immune Response to Cancer Therapy in Combination with Immune Checkpoint Inhibitors
 
 
Article
Peer-Review Record

4-Aminoquinoline-Based Adamantanes as Potential Anticholinesterase Agents in Symptomatic Treatment of Alzheimer’s Disease

Pharmaceutics 2022, 14(6), 1305; https://doi.org/10.3390/pharmaceutics14061305
by Katarina Komatović 1, Ana Matošević 2, Nataša Terzić-Jovanović 3, Suzana Žunec 2, Sandra Šegan 3, Mario Zlatović 1, Nikola Maraković 2, Anita Bosak 2,* and Dejan M. Opsenica 3,4,*
Reviewer 1:
Reviewer 2: Anonymous
Pharmaceutics 2022, 14(6), 1305; https://doi.org/10.3390/pharmaceutics14061305
Submission received: 23 May 2022 / Revised: 14 June 2022 / Accepted: 16 June 2022 / Published: 20 June 2022
(This article belongs to the Section Drug Targeting and Design)

Round 1

Reviewer 1 Report

The authors should discuss ferroptosis, which has been implicated as a mechanism of cell death in AD. As the compounds have antioxidant activity, it would be interesting if the authors write how these compounds could be a therapeutic candidate for ferroptosis leading to neurodegeneration. 

Author Response

Response to Reviewer 1 comments:

The authors would like to thank Reviewer 1 for her/his valuable comments on our manuscript. We have responded to all of the comments and revised the paper accordingly.

Comment: The authors should discuss ferroptosis, which has been implicated as a mechanism of cell death in AD. As the compounds have antioxidant activity, it would be interesting if the authors write how these compounds could be a therapeutic candidate for ferroptosis leading to neurodegeneration.

Response: The discussion of ferroptosis was added in the General Discussion section.

“Considerable antioxidant power of compounds 17, 18 and 19 to attenuate adverse effects of oxidative stress associated with AD could be considered as an additional target in terms of the design and development of 4-aminoquinolines as multi target drugs. This is especially interesting in terms of the ferroptosis, an iron-dependent mechanism of regulated cell death associated with the increase in oxidative stress generated by free radicals formed via the Fenton reaction. Due to its correlation to the etiopathology of AD, ferroptosis is proposed as a promising new target for the treatment of AD [72].”

Reviewer 2 Report

The manuscript is significantly improved, but the English should be revised by an English mother language reader. 

Author Response

Response to Reviewer 2 comments:

The authors would like to thank Reviewer 2 for her/his valuable comment on our manuscript. We have responded to the comment and revised the paper accordingly.

Comment: The manuscript is significantly improved, but the English should be revised by an English mother language reader.

Response: the manuscript was additionally revised by English nature speaker, Mrs Lynn Katsikas. All the changes are marked by Track changes.

Back to TopTop